Mentice AB (publ) (MNTC.ST)
SEK 18.55
(0.27%)
SEK 18.55
(0.27%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 236.38 Million SEK | -101.16% |
| 2022 | 188.94 Million SEK | 26.03% |
| 2021 | 149.91 Million SEK | 44.0% |
| 2020 | 104.1 Million SEK | -17.93% |
| 2019 | 126.85 Million SEK | -0.58% |
| 2018 | 127.59 Million SEK | 42.27% |
| 2017 | 89.68 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 17.5 Million SEK | 103.52% |
| 2024 Q1 | 42.41 Million SEK | 1606.11% |
| 2023 Q2 | 63.76 Million SEK | 13.24% |
| 2023 Q1 | 56.3 Million SEK | -12.38% |
| 2023 FY | -2.19 Million SEK | -101.16% |
| 2023 Q4 | -2.81 Million SEK | -105.1% |
| 2023 Q3 | 55.25 Million SEK | -13.34% |
| 2022 Q2 | 37.89 Million SEK | -10.89% |
| 2022 Q1 | 42.52 Million SEK | -20.52% |
| 2022 FY | 188.94 Million SEK | 26.03% |
| 2022 Q4 | 64.26 Million SEK | 45.2% |
| 2022 Q3 | 44.25 Million SEK | 16.79% |
| 2021 Q1 | 25.93 Million SEK | -10.74% |
| 2021 Q2 | 37 Million SEK | 42.68% |
| 2021 Q4 | 53.5 Million SEK | 60.27% |
| 2021 Q3 | 33.38 Million SEK | -9.8% |
| 2021 FY | 149.91 Million SEK | 44.0% |
| 2020 Q4 | 29.05 Million SEK | 3.19% |
| 2020 Q3 | 28.16 Million SEK | 54.32% |
| 2020 Q2 | 18.24 Million SEK | -36.28% |
| 2020 Q1 | 28.63 Million SEK | -43.73% |
| 2020 FY | 104.1 Million SEK | -17.93% |
| 2019 FY | 126.85 Million SEK | -0.58% |
| 2019 Q4 | 50.89 Million SEK | 94.68% |
| 2019 Q3 | 26.14 Million SEK | -1.31% |
| 2019 Q2 | 26.48 Million SEK | 13.55% |
| 2019 Q1 | 23.32 Million SEK | -53.46% |
| 2018 Q2 | 23.48 Million SEK | -1.96% |
| 2018 Q3 | 30.02 Million SEK | 27.86% |
| 2018 Q4 | 50.13 Million SEK | 66.95% |
| 2018 FY | 127.59 Million SEK | 42.27% |
| 2018 Q1 | 23.95 Million SEK | 0.0% |
| 2017 FY | 89.68 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acarix AB (publ) | 5.29 Million SEK | -4362.545% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 21.364% |
| ADDvise Group AB (publ) | 300.6 Million SEK | 21.364% |
| Arcoma AB | 11.07 Million SEK | -2035.137% |
| Bactiguard Holding AB (publ) | 139.98 Million SEK | -68.866% |
| BICO Group AB (publ) | 1.83 Billion SEK | 87.087% |
| Boule Diagnostics AB (publ) | 249.71 Million SEK | 5.339% |
| CellaVision AB (publ) | 463.04 Million SEK | 48.95% |
| Clinical Laserthermia Systems AB (publ) | 2.99 Million SEK | -7787.254% |
| Chordate Medical Holding AB (publ) | -28.41 Million SEK | 931.915% |
| C-Rad AB (publ) | 66.01 Million SEK | -258.072% |
| Duearity AB (publ) | -4.17 Million SEK | 5757.755% |
| Dignitana AB (publ) | 58.97 Million SEK | -300.843% |
| Episurf Medical AB (publ) | -41.8 Million SEK | 665.505% |
| Getinge AB (publ) | 13.43 Billion SEK | 98.24% |
| Scandinavian Real Heart AB (Publ) | -50.21 Million SEK | 570.716% |
| Iconovo AB (publ) | 17.57 Million SEK | -1244.781% |
| Integrum AB (publ) | 690.56 Thousand SEK | -34130.236% |
| Luxbright AB (publ) | -2.79 Million SEK | 8551.608% |
| OssDsign AB (publ) | 83.64 Million SEK | -182.6% |
| Paxman AB (publ) | 12.61 Million SEK | -1773.363% |
| Promimic AB (publ) | 38.51 Million SEK | -513.738% |
| Qlife Holding AB (publ) | -50.75 Million SEK | 565.748% |
| SciBase Holding AB (publ) | 16.03 Million SEK | -1373.973% |
| ScandiDos AB (publ) | 47.55 Million SEK | -397.069% |
| Sectra AB (publ) | 557.55 Million SEK | 57.604% |
| Sedana Medical AB (publ) | 108.98 Million SEK | -116.901% |
| Senzime AB (publ) | 8.33 Million SEK | -2734.644% |
| SpectraCure AB (publ) | -9.22 Million SEK | 2662.951% |
| Stille AB | 132.17 Million SEK | -78.845% |
| Vitrolife AB (publ) | 1.97 Billion SEK | 88.049% |
| Xvivo Perfusion AB (publ) | 416.91 Million SEK | 43.302% |